Human immunodeficiency virus (HIV) is a germ that causes a lifelong infection that slowly weakens the immune system. Though the infection is lifelong, medicines can keep the virus in check and help ...
The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.
A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.
Medicines that treat HIV are called antiretroviral therapy (ART). Genvoya is a combination tablet that contains the following four medicines that work together to treat HIV. Cobicistat is a “booster.” ...
Same-day ART initiation for patients with HIV infection and tuberculosis symptoms is as effective as deferring therapy until ...
About 1.2 million Americans are living with HIV (human immunodeficiency virus), the virus that causes AIDS (acquired immunodeficiency syndrome). Just a few decades ago, the AIDS epidemic was spiraling ...
At the cellular level, HIV-1 transmission involves a highly coordinated process whereby the virus binds to CD4 receptors and one of two coreceptors—CCR5 (R5) or CXCR4 (X4)—on host immune cells, ...
HIV is preventable, yet new diagnoses continue in AZ at higher-than-average rates. Could a new, twice-yearly shot called Yeztugo change that?
Peak anti-hepatitis B surface antibody levels predicted increased viral protection in HIV, a French study shows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results